Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1969 2
1972 1
1981 1
1987 1
1988 1
1989 1
1991 2
1995 1
2000 1
2003 1
2007 1
2012 1
2015 1
2016 1
2017 1
2018 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Approach to and treatment of goiters.
Medeiros-Neto G, Camargo RY, Tomimori EK. Medeiros-Neto G, et al. Med Clin North Am. 2012 Mar;96(2):351-68. doi: 10.1016/j.mcna.2012.01.010. Med Clin North Am. 2012. PMID: 22443980 Review.
The main causes of simple diffuse goiter (SDG) and multinodular goiter (MNG) are iodine deficiency, increase in serum thyroid-stimulating hormone (TSH) level, natural goitrogens, smoking, chronic malnutrition, and lack of selenium, iron, and zinc. ...Each of …
The main causes of simple diffuse goiter (SDG) and multinodular goiter (MNG) are iodine deficiency, increase in serum t …
Differential diagnosis of goiter.
Mahoney CP. Mahoney CP. Pediatr Clin North Am. 1987 Aug;34(4):891-905. doi: 10.1016/s0031-3955(16)36293-9. Pediatr Clin North Am. 1987. PMID: 3302898 Review.
Goiters appearing during childhood are the result of distinct diseases and should be investigated rather than attributed to "physiologic hyperplasia." The etiology of the diffuse goiter can often be established by clinical evaluation, performing thyroid function tes …
Goiters appearing during childhood are the result of distinct diseases and should be investigated rather than attributed to "physiologic hyp …
Therapeutic options in the management of toxic and nontoxic nodular goiter.
Freitas JE. Freitas JE. Semin Nucl Med. 2000 Apr;30(2):88-97. doi: 10.1053/nm.2000.4597. Semin Nucl Med. 2000. PMID: 10787189 Review.
The initial small diffuse goiter evolves into a multinodular goiter (MNG) with 1 or more dominant nodules that may or may not be autonomous. ...Thionamides control the hyperthyroidism of toxic nodular goiter in preparation for more definitive therap …
The initial small diffuse goiter evolves into a multinodular goiter (MNG) with 1 or more dominant nodules that may or m …
Prevalence of thyroid diffuse goiter and its association with body mass index and the presence of cysts and nodules in children and adolescents: the Fukushima Health Management Survey.
Nakahata N, Asano M, Abe N, Ejiri H, Ota H, Suzuki S, Sato A, Tazaki R, Nagamine N, Takahashi C, Yamaya Y, Iwadate M, Matsuzuka T, Ohira T, Yasumura S, Suzuki S, Furuya F, Shimura H, Suzuki S, Yokoya S, Ohto H, Kamiya K. Nakahata N, et al. Endocr J. 2024 Apr 30;71(4):383-393. doi: 10.1507/endocrj.EJ23-0609. Epub 2024 Mar 16. Endocr J. 2024. PMID: 38369332 Free article.
The main cause of diffuse thyroid goiter is autoimmune chronic thyroiditis, otherwise known as Hashimoto's thyroiditis. Thyroid hormones play pivotal roles in growth and development during childhood. However, the prevalence of diffuse goiter and the re …
The main cause of diffuse thyroid goiter is autoimmune chronic thyroiditis, otherwise known as Hashimoto's thyroiditis. Thyroi …
Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
Loy M, Perra E, Melis A, Cianchetti ME, Piga M, Serra A, Pinna G, Mariotti S. Loy M, et al. Acta Radiol. 2007 Jul;48(6):628-34. doi: 10.1080/02841850701342138. Acta Radiol. 2007. PMID: 17611870
Ten of the 11 patients in the first group showed a hypervascular nodular pattern, while one showed a hypervascular parenchymal pattern. Clinical diagnoses were toxic nodular goiter and Graves' disease, respectively. Of the 10 patients with low/no blood flow, six had normal …
Ten of the 11 patients in the first group showed a hypervascular nodular pattern, while one showed a hypervascular parenchymal pattern. Clin …
The effect of Metformin treatment in obese insulin-resistant patients with euthyroid goiter.
Răcătăianu N, Bolboacă SD, Sitar-Tăut AV, Mârza S, Moga D, Valea A, Ghervan C. Răcătăianu N, et al. Acta Clin Belg. 2018 Oct;73(5):317-323. doi: 10.1080/17843286.2018.1439273. Epub 2018 Feb 16. Acta Clin Belg. 2018. PMID: 29452573
Objective The study's objective was to evaluate the thyroid parameters in obese insulin-resistant patients with euthyroid diffuse or nodular goiter, following Metformin treatment. Patients and methods The study was experimental, open, and prospective. ...Obese insul …
Objective The study's objective was to evaluate the thyroid parameters in obese insulin-resistant patients with euthyroid diffuse or …
Diagnostic performance of thyroid ultrasonography screening in pediatric patients with a hypothyroid, hyperthyroid or euthyroid goiter.
Lee SJ, Lim GY, Kim JY, Chung MH. Lee SJ, et al. Pediatr Radiol. 2016 Jan;46(1):104-11. doi: 10.1007/s00247-015-3435-4. Epub 2015 Aug 23. Pediatr Radiol. 2016. PMID: 26298554
OBJECTIVE: To evaluate the usefulness of ultrasonography (US) in the identification of potential malignant nodules and autoimmune thyroiditis in children with diffuse goiter. MATERIALS AND METHODS: This study consisted of 113 patients <20 years with a diffuse …
OBJECTIVE: To evaluate the usefulness of ultrasonography (US) in the identification of potential malignant nodules and autoimmune thyroiditi …
Treatment of toxic diffuse goiter.
Stanbury JB. Stanbury JB. Postgrad Med. 1969 Jul;46(1):137-9. doi: 10.1080/00325481.1969.11697210. Postgrad Med. 1969. PMID: 4183010 No abstract available.
Differences and similarities in the treatment of diffuse goiter in Europe and the United States.
Wartofsky L, Glinoer D, Solomon B, Lagasse R. Wartofsky L, et al. Exp Clin Endocrinol. 1991 May;97(2-3):243-51. doi: 10.1055/s-0029-1211072. Exp Clin Endocrinol. 1991. PMID: 1717298
For the index patient, radioiodine (RAI) was the therapy of choice for 69% of ATA respondents but only 22% of ETA respondents. In contrast, only 30.5% of ATA respondents chose antithyroid drugs as first line therapy compared to 77% of ETA respondents. There was cons …
For the index patient, radioiodine (RAI) was the therapy of choice for 69% of ATA respondents but only 22% of ETA respondents. In con …
Incidence of Hypothyreoidism after Radioactive Iodine-I131 Treatment in Dependance of Hyperthyreoidism Etiology and Therapy Dose.
Beslic N, Licina S, Sadija A, Milardovic R. Beslic N, et al. Med Arch. 2017 Aug;71(4):270-273. doi: 10.5455/medarh.2017.71.270-273. Med Arch. 2017. PMID: 28974848 Free PMC article.
Hypothyreoidism in patients with diffuse goiter, Graves' disease and TA was mostly developed after I131 therapy with a dose quantity of 10.1-15 mCi and in MNG patients after RAI therapy with applied doses of 15.1-20 mCi. ...It's mostly developed after …
Hypothyreoidism in patients with diffuse goiter, Graves' disease and TA was mostly developed after I131 therapy with a …
19 results